Turn recording back on
Erosive arthritis.
Schett G.
Arthritis Res Ther. 2007;9 Suppl 1:S2. Review.
PMID: 17634141 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D.
Arthritis Rheum. 2008 Mar;58(3):718-29.
PMID: 18311801 [PubMed - indexed for MEDLINE]
Related Articles
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.
Rheumatology (Oxford). 2006 Sep;45(9):1068-76. Epub 2006 Feb 20.
PMID: 16490750 [PubMed - indexed for MEDLINE]
Mechanisms of Disease: the link between RANKL and arthritic bone disease.
Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS.
Nat Clin Pract Rheumatol. 2005 Nov;1(1):47-54. Review.
PMID: 16932627 [PubMed - indexed for MEDLINE]
Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.
Wu Y, Liu J, Feng X, Yang P, Xu X, Hsu HC, Mountz JD.
Arthritis Rheum. 2005 Oct;52(10):3257-68.
PMID: 16200600 [PubMed - indexed for MEDLINE]
Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
Weiss RJ, Erlandsson Harris H, Wick MC, Wretenberg P, Stark A, Palmblad K.
Scand J Immunol. 2005 Jul;62(1):55-62.
PMID: 16092922 [PubMed - indexed for MEDLINE]
What is the rank of RANKL in spondylarthritis?
Loddenkemper K, Burmester GR.
Arthritis Rheum. 2008 Mar;58(3):641-4. No abstract available.
PMID: 18311809 [PubMed - indexed for MEDLINE]
Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR.
J Rheumatol Suppl. 2002 Sep;65:44-8. Review. Erratum in: J Rheumatol Suppl. 2002 Nov;29(11):2471.
PMID: 12236623 [PubMed - indexed for MEDLINE]
New insights in the mechanism of bone loss in arthritis.
Schett G, Smolen JS.
Curr Pharm Des. 2005;11(23):3039-49. Review.
PMID: 16178762 [PubMed - indexed for MEDLINE]
Review: Immune cells and mediators of inflammatory arthritis.
Autoimmunity. 2008 Apr;41(3):224-9. Review.
PMID: 18365836 [PubMed - indexed for MEDLINE]
Rheumatic diseases: the effects of inflammation on bone.
Walsh NC, Crotti TN, Goldring SR, Gravallese EM.
Immunol Rev. 2005 Dec;208:228-51. Review.
PMID: 16313352 [PubMed - indexed for MEDLINE]
Rheumatoid arthritis: inflammation and bone loss.
Wien Med Wochenschr. 2006 Jan;156(1-2):34-41.
PMID: 16465612 [PubMed - indexed for MEDLINE]
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Zwerina J, Tuerk B, Redlich K, Smolen JS, Schett G.
Arthritis Res Ther. 2006;8(1):R22.
PMID: 16507121 [PubMed - indexed for MEDLINE]
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Herrak P, Görtz B, Hayer S, Redlich K, Reiter E, Gasser J, Bergmeister H, Kollias G, Smolen JS, Schett G.
Arthritis Rheum. 2004 Jul;50(7):2327-37.
PMID: 15248234 [PubMed - indexed for MEDLINE]
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G.
J Cell Physiol. 2004 May;199(2):244-51.
PMID: 15040007 [PubMed - indexed for MEDLINE]
CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, Tonnarelli B, Manferdini C, Facchini A.
J Cell Physiol. 2007 Mar;210(3):798-806.
PMID: 17133360 [PubMed - indexed for MEDLINE]
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
Romas E.
Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1065-79. Review.
PMID: 16301197 [PubMed - indexed for MEDLINE]
[Role of osteoclasts in bone destruction in rheumatoid arthritis]
Suzuki Y.
Nihon Rinsho Meneki Gakkai Kaishi. 2001 Jun;24(3):87-97. Review. Japanese. No abstract available.
PMID: 16578961 [PubMed - indexed for MEDLINE]
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, Boots AM, Gram H, Joosten LA, van den Berg WB.
Am J Pathol. 2005 Jul;167(1):141-9.
PMID: 15972960 [PubMed - indexed for MEDLINE]
[Molecular mechanisms of bone destruction in rheumatoid arthritis]
Nanki T.
Clin Calcium. 2007 Apr;17(4):510-6. Review. Japanese.
PMID: 17404479 [PubMed - indexed for MEDLINE]